CFLAR and hepatocellular carcinoma: For example, paclitaxel elevates the level of miR-512-3p that targets an anti-apoptotic gene, FADD-like apoptosis regulator (CFLAR, also known as c-FLIP), suggesting that miR-512-3p is responsible for paclitaxel-induced apoptosis to a degree in hepatocellular carcinoma cells [12].